Neurostimulation Devices Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boston Scientific Corporation
- Integer Holdings Corporation
- Medtronic
- Nevro Corp.
- NeuroSigma, Inc.
- NeuroPace, Inc.
- Neuronetics
- Synapse Biomedical Inc.
- Soterix Medical, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of neurostimulation devices is assessed at USD 9.13 billion.
The global neurostimulation devices market size was valued at over USD 8.23 billion in 2025 and is expected to expand at a CAGR of around 12.2%, surpassing USD 26.02 billion revenue by 2035.
North America’s neurostimulation devices market dominates with a 58.7% share by 2035, driven by rising prevalence of neurological disorders, a growing geriatric population, and increasing adoption of implantable neurostimulation devices.
Key players in the market include Abbott Laboratories, Boston Scientific Corporation, Integer Holdings Corporation, Medtronic, Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Synapse Biomedical Inc., Soterix Medical, Inc.
